Skip to main content
. 2023 Nov 28;21:407. doi: 10.1186/s12916-023-03107-y

Table 3.

Associations between total adherence score, categorised according to approximate score tertiles of the study population, and risk of all cancers combined and of cancers at individual anatomical sites

Low score (0–3.5) Mid score (3.75–4.25) Higher score (4.5–7)
Model 1 Model 2 Model 1 Model 2
Cancer site Total Incident cancers HR (95% CI) HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
All cancers combined 93,630 7296 1.00 (ref) 0.91 (0.86; 0.97) 0.001a 0.92 (0.87; 0.97) 0.004 0.83 (0.78; 0.87)  < 0.001a 0.84 (0.79; 0.89)  < 0.001a
Prostate 43,851 1818 1.00 (ref) 1.06 (0.95; 1.18) 0.275 1.06 (0.95; 1.18) 0.306 0.98 (0.87; 1.10) 0.686 0.96 (0.85; 1.08) 0.499
Breast 50,337 1438 1.00 (ref) 0.82 (0.72; 0.93) 0.003 0.82 (0.72; 0.94) 0.003 0.82 (0.73; 0.93) 0.001a 0.82 (0.73; 0.93) 0.002a
Pre-menopausal 1108 154 1.00 (ref) 0.58 (0.38; 0.89) 0.013 0.58 (0.38; 0.89) 0.013 0.67 (0.47; 0.97) 0.032 0.67 (0.47; 0.96) 0.031
Post-menopausal 49,229 1284 1.00 (ref) 0.83 (0.72; 0.96) 0.010 0.83 (0.72; 0.96) 0.011 0.81 (0.72; 0.93) 0.002a 0.82 (0.72; 0.93) 0.002a
Colorectal 94,656 862 1.00 (ref) 0.78 (0.66; 0.92) 0.004 0.79 (0.67; 0.93) 0.006 0.76 (0.65; 0.90) 0.001a 0.79 (0.66; 0.93) 0.005
Colon 94,698 575 1.00 (ref) 0.69 (0.56; 0.85)  < 0.001a 0.69 (0.57; 0.85) 0.001a 0.67 (0.55; 0.82)  < 0.001a 0.69 (0.56; 0.84)  < 0.001a
Distal 94,734 242 1.00 (ref) 0.62 (0.46; 0.86) 0.003 0.62 (0.45; 0.85) 0.003 0.54 (0.39; 0.76)  < 0.001a 0.56 (0.40; 0.77)  < 0.001a
Proximal 94,748 303 1.00 (ref) 0.77 (0.58; 1.02) 0.069 0.78 (0.59; 1.03) 0.084 0.75 (0.57; 1.00) 0.057 0.77 (0.58; 1.02) 0.067
Rectum 94,734 342 1.00 (ref) 0.97 (0.74; 1.25) 0.789 0.99 (0.76; 1.28) 0.943 0.97 (0.74; 1.26) 0.798 1.01 (0.78; 1.32) 0.926
Lung 94,760 431 1.00 (ref) 0.92 (0.73; 1.15) 0.465 1.02 (0.81; 1.27) 0.895 0.67 (0.52; 0.85) 0.001a 0.80 (0.63; 1.02) 0.073
Kidney 94,754 221 1.00 (ref) 0.85 (0.62; 1.16) 0.299 0.85 (0.62; 1.17) 0.322 0.64 (0.45; 0.90) 0.011 0.64 (0.45; 0.92) 0.014
Pancreas 94,770 213 1.00 (ref) 0.72 (0.52; 1.01) 0.061 0.74 (0.53; 1.04) 0.076 0.73 (0.52; 1.01) 0.058 0.75 (0.53; 1.04) 0.087
Uterus 50,588 212 1.00 (ref) 1.00 (0.71; 1.40) 0.994 0.99 (0.71; 1.39) 0.964 0.84 (0.61; 1.16) 0.287 0.83 (0.60; 1.14) 0.250
Oesophagus 94,765 151 1.00 (ref) 0.89 (0.61; 1.29) 0.534 0.92 (0.63; 1.34) 0.665 0.60 (0.39; 0.92) 0.020 0.64 (0.41; 0.99) 0.046
Ovary 50,603 147 1.00 (ref) 0.69 (0.46; 1.03) 0.071 0.69 (0.46; 1.03) 0.070 0.57 (0.39; 0.84) 0.005 0.57 (0.39; 0.84) 0.005
Bladder 94,756 141 1.00 (ref) 0.70 (0.47; 1.06) 0.093 0.73 (0.48; 1.10) 0.135 0.67 (0.43; 1.03) 0.066 0.72 (0.47; 1.11) 0.137
Head and Neck 94,763 129 1.00 (ref) 1.45 (0.95; 2.22) 0.086 1.51 (0.98; 2.31) 0.060 1.42 (0.93; 2.18) 0.108 1.52 (0.99; 2.33) 0.057
Stomach 94,770 99 1.00 (ref) 1.01 (0.63; 1.62) 0.982 1.02 (0.64; 1.65) 0.920 0.94 (0.57; 1.54) 0.804 0.97 (0.59; 1.59) 0.899
Liver 94,773 82 1.00 (ref) 0.78 (0.46; 1.33) 0.364 0.80 (0.47; 1.35) 0.397 0.66 (0.38; 1.15) 0.142 0.68 (0.39; 1.18) 0.172
Gallbladder 94,777 49 1.00 (ref) 0.68 (0.34; 1.35) 0.269 0.67 (0.34; 1.33) 0.251 0.56 (0.27; 1.15) 0.115 0.54 (0.26; 1.12) 0.098

Data are presented as hazard ratio (HR) with 95% confidence intervals in parentheses (95% CIs). Lowest score tertile was the reference group. Model 1 was adjusted for age, sex, Townsend deprivation index, and ethnicity. Model 2 was additionally adjusted for smoking status

aFollowing correction using the Holm-Bonferroni method P < 0.05